950 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 950 shares of the healthcare conglomerate’s stock, valued at approximately $500,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Richelieu Gestion SA acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC increased its position in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC grew its stake in UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares during the last quarter. LFA Lugano Financial Advisors SA grew its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares during the period. Finally, Annapolis Financial Services LLC increased its position in shares of UnitedHealth Group by 38.6% in the third quarter. Annapolis Financial Services LLC now owns 79 shares of the healthcare conglomerate’s stock valued at $40,000 after buying an additional 22 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

UNH has been the topic of several recent analyst reports. Truist Financial reaffirmed a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Piper Sandler raised their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, January 17th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research report on Thursday, April 4th. Finally, Royal Bank of Canada lowered their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Insider Buying and Selling

In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Trading Up 0.8 %

Shares of NYSE UNH traded up $3.84 during trading on Thursday, reaching $507.05. The stock had a trading volume of 2,342,947 shares, compared to its average volume of 4,341,180. The company has a market cap of $466.53 billion, a P/E ratio of 30.99, a PEG ratio of 1.43 and a beta of 0.55. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The business’s 50-day moving average price is $481.55 and its 200-day moving average price is $511.92. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the previous year, the business posted $6.26 earnings per share. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.48%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.